These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study. Vannucchi G; Covelli D; Campi I; Currò N; Dazzi D; Rodari M; Pepe G; Chiti A; Guastella C; Lazzaroni E; Salvi M Thyroid; 2019 Dec; 29(12):1828-1833. PubMed ID: 31860407 [No Abstract] [Full Text] [Related]
3. Color Doppler imaging of the superior ophthalmic vein in different clinical forms of Graves' orbitopathy. Monteiro MLR; Angotti-Neto H; Benabou JE; Betinjane AJ Jpn J Ophthalmol; 2008; 52(6):483-488. PubMed ID: 19089570 [TBL] [Abstract][Full Text] [Related]
4. Dysthyroid orbitopathy and orbital decompression. A review. Jorissen M; Feenstra L Acta Otorhinolaryngol Belg; 1992; 46(3):303-9. PubMed ID: 1414313 [TBL] [Abstract][Full Text] [Related]
5. Graves' orbitopathy and restrictive myopathy. Biedner B; Marcus M; Yassur Y Thyroidology; 1991 May; 3(2):79-83. PubMed ID: 1726905 [TBL] [Abstract][Full Text] [Related]
11. [Evaluation of radioiodine 131I treatment in Graves' disease patients with mild orbitopathy]. Bałdys-Waligórska A; Stefańska A; Gołkowski F; Sokołowski G; Hubalewska-Dydejczyk A Przegl Lek; 2009; 66(4):166-9. PubMed ID: 19708504 [TBL] [Abstract][Full Text] [Related]
12. Intraocular pressure changes after treatment for Graves' orbitopathy. Danesh-Meyer HV; Savino PJ; Deramo V; Sergott RC; Smith AF Ophthalmology; 2001 Jan; 108(1):145-50. PubMed ID: 11150280 [TBL] [Abstract][Full Text] [Related]
13. An individualized approach to orbital decompression in Graves' orbitopathy. Hurwitz JJ; Birt D Arch Ophthalmol; 1985 May; 103(5):660-5. PubMed ID: 3838890 [TBL] [Abstract][Full Text] [Related]
14. A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves' orbitopathy. Johnson KT; Wittig A; Loesch C; Esser J; Sauerwein W; Eckstein AK Graefes Arch Clin Exp Ophthalmol; 2010 Jan; 248(1):103-9. PubMed ID: 19865824 [TBL] [Abstract][Full Text] [Related]
15. Orbital decompression for non-Graves' orbitopathy: a consideration of extended indications for decompression. Goldberg RA; Hwang MM; Garbutt MV; Shorr N Ophthalmic Plast Reconstr Surg; 1995 Dec; 11(4):245-52; discussion 253. PubMed ID: 8746815 [TBL] [Abstract][Full Text] [Related]
16. Transorbital approach to decompression in Graves' disease. Anderson RL; Linberg JV Arch Ophthalmol; 1981 Jan; 99(1):120-4. PubMed ID: 6893929 [TBL] [Abstract][Full Text] [Related]
18. Current and Emerging Treatment Strategies for Graves' Orbitopathy. Genere N; Stan MN Drugs; 2019 Feb; 79(2):109-124. PubMed ID: 30659423 [TBL] [Abstract][Full Text] [Related]
19. Histopathology of brow fat in thyroid-associated orbitopathy. Hwang CJ; Khadavi NM; Papageorgiou K; Said J; Chong K; Lee D; Smith TJ; Goldberg RA; Douglas RS Ophthalmic Plast Reconstr Surg; 2012; 28(1):27-9. PubMed ID: 22082595 [TBL] [Abstract][Full Text] [Related]
20. The tale of radioiodine and Graves' orbitopathy. Ponto KA; Zang S; Kahaly GJ Thyroid; 2010 Jul; 20(7):785-93. PubMed ID: 20578895 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]